Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
The Journal of Urology|November 28, 2022
A Multicenter, Randomized, Single-blind, 2-Arm Intervention Study Evaluating the Adverse Events and Quality of Life After Irreversible Electroporation for the Ablation of Localized Low-intermediate Risk Prostate CancerJean de la Rosette, Jose Dominguez-Escrig, Kai Zhang, et al.
JAMA Surgery|February 1, 2023
Effect of Focal vs Extended Irreversible Electroporation for the Ablation of Localized Low- or Intermediate-Risk Prostate Cancer on Early Oncological Control: A Randomized Clinical TrialKai Zhang, Jeremy Teoh, Pilar Laguna, et al.
BJU International|April 4, 2025
The diagnostic value of MRI for persistent prostate cancer following irreversible electroporation focal therapyKai Zhang, Jeremy Teoh, Pilar Laguna, et al.
BJU International|June 19, 2013
Definitions of terms, processes and a minimum dataset for transperineal prostate biopsies: a standardization approach of the Ginsburg Study Group for Enhanced Prostate DiagnosticsTimur H Kuru, Karan Wadhwa, Richard Tsung Meng Chang, et al.
European Urology|December 17, 2013
180-W XPS GreenLight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European Multicentre Randomised Trial--the GOLIATH studyAlexander Bachmann, Andrea Tubaro, Neil Barber, et al.
European Urology|August 19, 2015
A Multicenter Randomized Noninferiority Trial Comparing GreenLight-XPS Laser Vaporization of the Prostate and Transurethral Resection of the Prostate for the Treatment of Benign Prostatic Obstruction: Two-yr Outcomes of the GOLIATH StudyJames A Thomas, Andrea Tubaro, Neil Barber, et al.
The Journal of Urology|September 16, 2014
A European multicenter randomized noninferiority trial comparing 180 W GreenLight XPS laser vaporization and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 12-month results of the GOLIATH studyAlexander Bachmann, Andrea Tubaro, Neil Barber, et al.
Pageof 8